mhurhangee/ep-ind-claims huggingface dataset:
Apparatus comprising: an electric double layer capacitor having a first surface and a second surface, the first surface being opposite the second surface; a first conductor, comprising at least an antenna, configured at least for wireless communication, positioned adjacent the first surface and configured to function as a current collector for the electric double layer capacitor, and having a first electrical length to resonate in a first operational frequency band; and a second conductor, comprising at least an antenna, positioned adjacent the second surface and configured to function as a current collector for the electric double layer capacitor. an electric double layer capacitor having a first surface and a second surface, the first surface being opposite the second surface; a first conductor, comprising at least an antenna, configured at least for wireless communication, positioned adjacent the first surface and configured to function as a current collector for the electric double layer capacitor, and having a first electrical length to resonate in a first operational frequency band; and a second conductor, comprising at least an antenna, positioned adjacent the second surface and configured to function as a current collector for the electric double layer capacitor.
Device for forming bristle bundles of a bristle complement of a brush that comprises at least two bristle bundles, wherein the device has at least one bundle pocket having at least two bundle receptacles configured therein and a heating apparatus, characterized in that the heating apparatus is specified for heating the at least one bundle pocket and the bristle bundles that have been incorporated into the bundle receptacles, wherein the bundle receptacles are bundle-forming and, under the effect of heat dissipated by the heating apparatus on the bundle pocket and thus on the bristle bundles situated therein, specified for forming bristle bundles that have been incorporated into the bundle receptacles in comparison to the shape of said bristle bundles prior to being introduced into the bundle receptacles so as to set the shaping of the bristle bundles that have been incorporated into the bundle receptacles to the shaping predefined by the bundle receptacles, and wherein the bundle pocket has at least two bundle receptacles which open into a common bundle receptacle portion, and/or wherein the bundle pocket has at least one bundle receptacle which is specified for receiving at least two bristle bundles and comprises a common bundle receptacle portion for at least two bristle bundles.
An electronic percussion instrument comprising: a first frame having an upper surface configured as a hit surface; a first sensor attached to the first frame for detecting vibration of a hit to the first frame; a second frame disposed below the first frame in a non-contact state with the first frame and having an outer edge that is located on an outer peripheral side of an outer edge of the first frame to form an edge portion, a second sensor attached to the second frame for detecting vibration of a hit to the second frame, and an elastic body supported by a rod, wherein the first frame and the second frame are supported by the rod via the elastic body, wherein the electronic percussion instrument is characterized in that the electronic percussion instrument further comprises a cushioning material having a predetermined elasticity and provided between a lower surface of the outer edge side of the first frame and an upper surface of the second frame, wherein contact between the first frame and the second frame is restricted by the cushioning material in response to the first frame or the second frame being hit. a first frame having an upper surface configured as a hit surface; a first sensor attached to the first frame for detecting vibration of a hit to the first frame; a second frame disposed below the first frame in a non-contact state with the first frame and having an outer edge that is located on an outer peripheral side of an outer edge of the first frame to form an edge portion, a second sensor attached to the second frame for detecting vibration of a hit to the second frame, and an elastic body supported by a rod, wherein the first frame and the second frame are supported by the rod via the elastic body, wherein the electronic percussion instrument is characterized in that the electronic percussion instrument further comprises a cushioning material having a predetermined elasticity and provided between a lower surface of the outer edge side of the first frame and an upper surface of the second frame, wherein contact between the first frame and the second frame is restricted by the cushioning material in response to the first frame or the second frame being hit.
A method for beamforming, the method being performed by a network node, wherein the network node is capable of communicating with served wireless devices (300a, 300b, 300c) using multiple beams (150, 150a, 150b, 150c, 150d, 150K) generated by analog beamforming in an antenna array, the method comprising: identifying, based on statistics of handovers of the served wireless devices (300a, 300b, 300c) between the beams (150, 150a, 150b, 150c, 150d, 150K), a need to combine at least two of the beams (150, 150a, 150b, 150c, 150d, 150K) into a new beam (160a, 160b), wherein, in angular space, the new beam (160a, 160b) covers said at least two of the beams (150, 150a, 150b, 150c, 150d, 150K) that are combined into the new beam (160a, 160b); determining beamforming weights to be applied at the analog antenna array for generating the new beam (160a, 160b); and communicating with the served wireless devices (300a, 300b, 300c) using the new beam (160a, 160b) with the determined beamforming weights having been applied at the analog antenna array. identifying, based on statistics of handovers of the served wireless devices (300a, 300b, 300c) between the beams (150, 150a, 150b, 150c, 150d, 150K), a need to combine at least two of the beams (150, 150a, 150b, 150c, 150d, 150K) into a new beam (160a, 160b), wherein, in angular space, the new beam (160a, 160b) covers said at least two of the beams (150, 150a, 150b, 150c, 150d, 150K) that are combined into the new beam (160a, 160b); determining beamforming weights to be applied at the analog antenna array for generating the new beam (160a, 160b); and communicating with the served wireless devices (300a, 300b, 300c) using the new beam (160a, 160b) with the determined beamforming weights having been applied at the analog antenna array.
A wear assembly for earth working equipment comprising: a wear member to contact earthen material including a mounting portion for securing the wear member to the earth working equipment, the mounting portion including an inner surface to face the earth working equipment, an opposite outer surface, and an opening extending through the mounting portion and open in the inner surface and the outer surface, the opening including a bearing surface facing away from the inner surface; a retainer in the opening, the retainer including a bore having a bore axis, characterised in that the retainer further includes a main axis parallel to and offset from the bore axis such that the retainer is eccentric; and a bolt to contact the earth working equipment and thread into the bore to pull the retainer against the bearing surface and thereby secure the wear member to the earth working equipment, and to cause the retainer to turn about the bore axis to move the wear member in a direction transverse to the bore axis and thereby tighten the fit of the wear member on the earth working equipment. a wear member to contact earthen material including a mounting portion for securing the wear member to the earth working equipment, the mounting portion including an inner surface to face the earth working equipment, an opposite outer surface, and an opening extending through the mounting portion and open in the inner surface and the outer surface, the opening including a bearing surface facing away from the inner surface; a retainer in the opening, the retainer including a bore having a bore axis, characterised in that the retainer further includes a main axis parallel to and offset from the bore axis such that the retainer is eccentric; and a bolt to contact the earth working equipment and thread into the bore to pull the retainer against the bearing surface and thereby secure the wear member to the earth working equipment, and to cause the retainer to turn about the bore axis to move the wear member in a direction transverse to the bore axis and thereby tighten the fit of the wear member on the earth working equipment.
Antibody fragment comprising a first polypeptide comprising a light chain variable domain and two constant domains and a second polypeptide comprising a heavy chain variable domain and two constant domains, wherein two constant domains are light chain constant domains and two constant domains are heavy chain CH1 constant domains, wherein said antibody fragment has prolonged in vivo half-life with respect to a Fab fragment comprising said light and heavy chain variable domains, wherein the first polypeptide comprises one light chain variable domain and two human light chain constant domains, wherein the light chain variable domain is fused to the first human light chain constant domain that is fused to the second light chain constant domain in the N- to C-terminal direction, thus generating a VL-CL-CL chimeric light chain, and wherein the second polypeptide comprises one heavy chain variable domain and two human heavy chain constant domains, wherein the heavy chain variable domain is fused to the first human heavy chain CH1 constant domain that is fused to the second human heavy chain CH1 constant domain in the N- to C-terminal direction, thus generating a VH-CH1-CH1 chimeric heavy chain.
Method to control an adjustment device of a motor vehicle, having an adjustment part which is driven by a motor, in which the speed of the drive is regulated to a speed target value at least in a partial region of an adjustment path during normal operation and the drive force is regulated to a force target value in the case of sluggishness for a first period, wherein, after the expiry of the first period - either the adjustment part is reversed or the drive is at least stopped, if a jam is recognised, - or the speed of the drive is regulated again to the speed target value if the case of sluggishness is not a jam, characterised in that the drive force is reduced at least to a first force in the case of detection of sluggishness and is increased to the force target value within a second period. - either the adjustment part is reversed or the drive is at least stopped, if a jam is recognised, - or the speed of the drive is regulated again to the speed target value if the case of sluggishness is not a jam,
A control unit assembly for a medical device wherein the assembly comprises a control unit and a docking unit, the docking unit located on the medical device, the medical device comprising a compression device for a limb, the compression device comprising a sleeve with inflatable cells; the control unit comprising a pump, at least two conduits and control means for controlling the flow of fluid from the pump through the conduits, characterised in that: the docking unit comprises a backing plate which carries rigid fluid transfer connectors which detachably connect the conduits to inflatable cells of the device; the conduits each comprise a rigid internal passage located in the control unit which terminates in a connector configured to make a detachable connection between the control unit and the docking unit so that the control unit can be readily attached and detached from the device; each connector of the control unit able to engage the fluid transfer connector of the docking unit to form a fluid tight seal and the control unit slides into connection with the backing plate to form the fluid tight seal. the docking unit comprises a backing plate which carries rigid fluid transfer connectors which detachably connect the conduits to inflatable cells of the device; the conduits each comprise a rigid internal passage located in the control unit which terminates in a connector configured to make a detachable connection between the control unit and the docking unit so that the control unit can be readily attached and detached from the device; each connector of the control unit able to engage the fluid transfer connector of the docking unit to form a fluid tight seal and the control unit slides into connection with the backing plate to form the fluid tight seal.
An asparatyl (asparaginyl) beta-hydroxylase (ASPH) inhibitory compound for use in a method of reducing proliferation, migration, invasion, or metastasis of a tumor cell in the treatment of cell proliferative disorder, comprising contacting said tumor cell with the ASPH inhibitory compound, wherein the ASPH inhibitory compound is of Formula Ia or Ib: or a salt, ester, or solvate thereof, wherein Ar 1 is substituted or unsubstituted C 6 -C 20 aryl or 5 to 20-membered heteroaryl; X is S 2, C, or C; W 1 is CR 50 R 51, a single bond, or NR 52 when X is SO 2, and W 1 is a single bond, CR 50 R 51, O, or NR 52 when X is CO; and each of R 50, R 51, R 52, and R 53 independently is selected from the group consisting of hydrogen, substituted or unsubstituted C 1 -C 6 alkyl, substituted or unsubstituted C 2 -C 6 alkenyl, substituted or unsubstituted C 2 -C 6 alkynyl, substituted or unsubstituted C 6 -C 20 aryl, substituted or unsubstituted C 7 -C 26 arylalkyl, substituted or unsubstituted 5 to 20-membered heteroaryl, and substituted or unsubstituted 6-26 membered heteroarylalkyl Ar 1 is substituted or unsubstituted C 6 -C 20 aryl or 5 to 20-membered heteroaryl; X is S 2, C, or C; W 1 is CR 50 R 51, a single bond, or NR 52 when X is SO 2, and W 1 is a single bond, CR 50 R 51, O, or NR 52 when X is CO; and each of R 50, R 51, R 52, and R 53 independently is selected from the group consisting of hydrogen, substituted or unsubstituted C 1 -C 6 alkyl, substituted or unsubstituted C 2 -C 6 alkenyl, substituted or unsubstituted C 2 -C 6 alkynyl, substituted or unsubstituted C 6 -C 20 aryl, substituted or unsubstituted C 7 -C 26 arylalkyl, substituted or unsubstituted 5 to 20-membered heteroaryl, and substituted or unsubstituted 6-26 membered heteroarylalkyl
A functional in vitro cell and tissue assay method for obtaining and/or profiling a compound of interest comprising: (a) cultivating a biological material comprising cells, a cell aggregate, tissue or an organ, on an electrode array; (b) subjecting said biological material to a test substance; and (c) measuring electrical activity of said biological material through said electrode array, and analyzing any one or all of the following parameters: (i) Na + channels; (ii) Ca 2+ /K + channels; (iii) K + channels; (iv) Amplitude and/or Field potential duration; (v) Chronotrophy of cardiac cells or burst periods of neuronal cells; (vi) Arrhythmias, EAD like phenomena; (vii) pH-value; (viii) oxygen partial pressure; (ix) Beating arrest; and/or (x) Analysis of AV-Dissociation contractility, NO-effects, and/or morphological changes; wherein said cells, cell aggregate, tissue and organ are obtained from stem cells that are genetically altered to comprise a selectable marker operably linked to a first cell type specific regulatory sequence specific for the first cell type and differentiated and depleted of relatively undifferentiated cells and/or of undesired cell types by using a selection system that is lethal to the undesired cells and cell types, by expressing a selectable marker gene that renders cells of specific cell type resistant to the lethal effect. (a) cultivating a biological material comprising cells, a cell aggregate, tissue or an organ, on an electrode array; (b) subjecting said biological material to a test substance; and (c) measuring electrical activity of said biological material through said electrode array, and analyzing any one or all of the following parameters: (i) Na + channels; (ii) Ca 2+ /K + channels; (iii) K + channels; (iv) Amplitude and/or Field potential duration; (v) Chronotrophy of cardiac cells or burst periods of neuronal cells; (vi) Arrhythmias, EAD like phenomena; (vii) pH-value; (viii) oxygen partial pressure; (ix) Beating arrest; and/or (x) Analysis of AV-Dissociation contractility, NO-effects, and/or morphological changes; (i) Na + channels; (ii) Ca 2+ /K + channels; (iii) K + channels; (iv) Amplitude and/or Field potential duration; (v) Chronotrophy of cardiac cells or burst periods of neuronal cells; (vi) Arrhythmias, EAD like phenomena; (vii) pH-value; (viii) oxygen partial pressure; (ix) Beating arrest; and/or (x) Analysis of AV-Dissociation contractility, NO-effects, and/or morphological changes;
Speed monitoring method in an automation system for a conveyor installation, especially for a pit installation, in which - a current path value (X a) and a current speed value (V a) are determined by means at least one pulse counter (18, 20, 22), - using the current path value (X a) a first speed limiting value (V 1) and a second speed limiting value (V 2) are determined and are compared with the current speed value (V a) in each case, - with the second speed limiting value (V 2) being read out from a data table representing a stepped limiting value curve stored in the automation system, characterised in that, the first speed limiting value (V 1) is calculated by means of a computing instruction stored in the automation system, wherein the first (V 1) and the second speed limiting value (V 2) are a speed limiting value in each case and an action which influences safety in the automation system being initiated if the first speed limiting value (V 1) and/or of the second speed limiting value (V 2) are exceeded by the actual speed value (V a). - a current path value (X a) and a current speed value (V a) are determined by means at least one pulse counter (18, 20, 22), - using the current path value (X a) a first speed limiting value (V 1) and a second speed limiting value (V 2) are determined and are compared with the current speed value (V a) in each case, - with the second speed limiting value (V 2) being read out from a data table representing a stepped limiting value curve stored in the automation system,
A sealing structure of a fuel cell in which first GDLs (2, 3), second GDLs (4, 5) and separators (6, 7) are laminated in order on both sides in a thickness direction of an MEA, and in which said MEA or a reinforcing frame integrated with the MEA is sandwiched by gaskets (8, 9) which are integrally provided on the respective separators (6, 7) positioned at both sides thereof in the thickness direction and are made of rubber or a synthetic resin material having rubber-like elasticity, at an outer side of said first GDLs (2, 3) and the second GDLs (4, 5), wherein end portions (2a, 3a) of said first GDLs (2, 3) are formed in such a size as to protrude beyond outer peripheries of said second GDLs (4, 5), said second GDLs (4, 5) are positioned on inner peripheries of said gaskets (8, 9), end portions (2a, 3a) of said first GDLs (2, 3) are positioned by support step portions (8a, 9a) formed in said gaskets (8, 9), and the end portions (2a, 3a) of said first GDLs (2, 3) are supported by the support step portions (8a, 9a) at a height which is approximately the same as a support height of said first GDLs (2, 3) by said second GDLs (4, 5).
Waterless urinal, comprising a trough and an exchangeable filter insert which is inserted into the trough and comprises a pot in which a siphon is provided and which comprises a cover that upwardly seals the pot and has a depression in which at least one opening is provided, which is sealed by an odour-sealing membrane which is permeable to urine, but is substantially gas-tight, and is pretensioned by a tension element (30, 26) against a sealing surface on the cover, wherein a separating wall is attached to the cover which divides the interior of the pot into a first chamber and a second chamber and in the installed state forms the siphon in conjunction with the liquid present in the pot, characterised in that the odour-sealing membrane is formed as a resilient disk.
Cooling assembly for a motor vehicle, comprising at least one first heat exchanger mainly extending in a first plane, at least one second heat exchanger mainly extending in a second plane and at least one protective grid for protecting the second heat exchanger, the first heat exchanger and/or the second heat exchanger being supported by a frame, characterized in that the at least one protective grid for protecting the second heat exchanger forms a one-piece part with the frame.
A method of determining whether a patient having a proneural glioblastoma is likely to respond to treatment with a VEGF antagonist, the method comprising: (a) detecting expression of NCAM1, OMG, PRKCZ, GALNT13, GPR17, DNM3, FERMT1, SNAP91, ABHD6, and PFN2 in a biological sample obtained from the patient prior to administration of a VEGF antagonist to the patient; and (b) comparing the expression level of NCAM1, OMG, PRKCZ, GALNT13, GPR17, DNM3, FERMT1, SNAP91, ABHD6, and PFN2 to a reference expression level of NCAM1, OMG, PRKCZ, GALNT13, GPR17, DNM3, FERMT1, SNAP91, ABHD6, and PFN2, wherein a change in the level of expression of NCAM1, OMG, PRKCZ, GALNT13, GPR17, DNM3, FERMT1, SNAP91, ABHD6, and PFN2 in the patient sample relative to the reference level identifies a patient who is likely to respond to treatment with a VEGF antagonist, wherein the change in the level of expression of NCAM1, OMG, PRKCZ, GALNT13, GPR17, DNM3, FERMT1, SNAP91, ABHD6, and PFN2 in the patient sample is an increase relative to the reference level. (a) detecting expression of NCAM1, OMG, PRKCZ, GALNT13, GPR17, DNM3, FERMT1, SNAP91, ABHD6, and PFN2 in a biological sample obtained from the patient prior to administration of a VEGF antagonist to the patient; and (b) comparing the expression level of NCAM1, OMG, PRKCZ, GALNT13, GPR17, DNM3, FERMT1, SNAP91, ABHD6, and PFN2 to a reference expression level of NCAM1, OMG, PRKCZ, GALNT13, GPR17, DNM3, FERMT1, SNAP91, ABHD6, and PFN2, wherein a change in the level of expression of NCAM1, OMG, PRKCZ, GALNT13, GPR17, DNM3, FERMT1, SNAP91, ABHD6, and PFN2 in the patient sample relative to the reference level identifies a patient who is likely to respond to treatment with a VEGF antagonist, wherein the change in the level of expression of NCAM1, OMG, PRKCZ, GALNT13, GPR17, DNM3, FERMT1, SNAP91, ABHD6, and PFN2 in the patient sample is an increase relative to the reference level.